Hollo

Hollo is a Hong Kong healthtech company developing a clinical-grade digital therapeutics and software medical device platform focused on the mental health and behavioral needs of patients with chronic diseases. The company combines behavioral health AI, digital biomarkers, gamified treatment tools, and measurement software to help healthcare providers measure, track, and treat comorbid mental health conditions. Its products are positioned as non-pharmacological digital interventions that integrate with providers and existing health technology workflows. Hollo also highlights a pipeline of digital therapeutics and software medical devices that it says are being clinically studied and are in the pipeline for FDA approvals. The company appears to be a private, early-stage platform business rather than a traditional therapeutics developer.